I migliori medici per il trattamento di Cancro osseo a Ramat Gan - TOP-3 medici

Dr. Yuri Goldes is a general surgeon with more than 20 years of clinical experience. He specializes in upper gastrointestinal and oncologic surgery. He is Deputy Director of the Department of General Surgery and Transplantation at Sheba Medical Center in Tel Aviv. He also leads the Upper GI Surgery Unit. He was named to Forbes Israel’s Best Doctors in 2025. He is ranked among Israel’s Best Gastrointestinal Surgeons by Forbes. In 2019, he received the Israeli Ministry of Health “Best Doctor of the Year” award.

He is an expert in advanced minimally invasive and robotic surgery. He treats diaphragmatic hernia, achalasia, GERD, and gallbladder disease. He also performs oncologic surgery for pancreatic, gastric, and esophageal cancers. He uses laparoscopic and robotic techniques.

He pioneered some of Israel’s first robotic oncologic resections of the stomach and pancreas. He is among a small group worldwide who perform minimally invasive Whipple procedures (pancreaticoduodenectomy) using advanced laparoscopy. He applies methods that improve outcomes and speed recovery. He provides personalized care.

Professor Raanan Berger, MD PhD, is a medical oncologist and radiotherapist. He is Director of the Cancer Center at Sheba Medical Center and heads its clinical research unit. He was listed in Forbes Israel’s “Best Doctors” (2025). He leads the genitourinary oncology program with a focus on prostate cancer. His care includes systemic therapy and radiotherapy in a multidisciplinary, patient-centered model.

He is board-certified in oncology. He earned his MD and PhD at Tel Aviv University and completed his clinical training at Sheba. He then completed a postdoctoral fellowship at Dana-Farber/Harvard, focusing on prostate cancer with Dr. Philip Kantoff and molecular oncology in Dr. William C. Hahn’s lab. He is a member of ESMO and ASCO. He has co-authored more than 20 peer-reviewed papers, including studies on outcomes in high- versus very high-risk prostate cancer and on BRCA1/2 in large cohorts.

Dr. Eytan Aharon Ben-Ami, MD

Senior Physician, Sarcoma & Bone Oncology Service – Sheba Medical Center

Leading Expert in Sarcoma, Bone Tumors & Innovative Cancer Therapies

Dr. Eytan Ben-Ami is a highly specialized medical oncologist with extensive experience in the treatment of sarcomas and complex bone tumors, including rare and aggressive cancers.

As a senior physician at Sheba Medical Center, he plays a key role in delivering multidisciplinary, highly personalized care, often collaborating with pediatric and adult oncology teams to manage challenging soft tissue and bone malignancies.

Areas of Expertise

• Sarcoma (Core Expertise)
  Soft tissue sarcomas, liposarcoma, leiomyosarcoma, and rare tumor subtypes
•  
• Bone Oncology
  Osteosarcoma and other primary bone tumors
•  
• Advanced Medical Oncology
  • Targeted therapies and immunotherapy
  •  
  • Personalized treatment protocols for rare cancers
  •  
• Early-Phase Clinical Trials (Phase I)
  Access to innovative and next-generation cancer treatments

Clinical Leadership & Innovation

Dr. Ben-Ami is at the forefront of oncology innovation at Sheba, contributing to:

• Leadership in early-phase (Phase I) clinical trials, offering patients access to cutting-edge therapies
• Development of new treatment approaches for rare cancers
• Implementation of patient-centered innovations, including novel care delivery models

He also founded Sheba’s Clinical Research Organization (CRO), a pioneering initiative supporting advanced clinical research across multiple disciplines.

International Training & Expertise

Dr. Ben-Ami completed a prestigious fellowship in Sarcoma and Bone Oncology at the Dana-Farber Cancer Institute / Harvard Cancer Center, one of the world’s leading cancer research institutions.

His approach combines:

• Global expertise in rare tumor management
• Advanced diagnostics and precision oncology
• Access to innovative therapies not widely available

Leadership & Academic Roles

• Senior Physician, Sarcoma & Bone Oncology Service, Sheba Medical Center
• Head of Oncology Division & Early-Phase Clinical Trials Unit
• Founder, Sheba Clinical Research Organization (CRO)
• Academic affiliation with Tel Aviv University

Research & Scientific Contribution

Dr. Ben-Ami is an active researcher with 40+ scientific publications, focusing on:

• Early detection and monitoring of sarcomas
• Molecular and viral mechanisms in rare tumors
• Development of innovative oncology treatments

He is also leading pilot programs in advanced immunotherapy delivery, improving accessibility and patient experience.

Clinical Approach

Dr. Ben-Ami is known for managing complex and rare cancer cases, offering:

• Highly individualized treatment strategies
• Multidisciplinary collaboration across oncology, surgery, and pediatrics
• Access to breakthrough therapies through clinical trials

Patient-Centered Care

Dr. Ben-Ami provides advanced, compassionate oncology care, combining cutting-edge science with a personalized approach, ensuring patients receive the most effective and innovative treatment options available.

A Leader in Rare Cancer Treatment

Through his expertise in sarcoma, bone oncology, and early-phase clinical research, Dr. Ben-Ami offers patients access to one of the most advanced programs globally for rare and complex cancers.